Previous studies have shown that the CXCL12/CXCR4 chemokine axis plays a critical role in localizing tumor cells to the bone marrow during the early stages of bone metastasis in prostate cancer (Sun et al., 2005; Shiozawa et al., 2011). This evidence concerns the gene CXCR4 and prostate carcinoma.